glp 1 hba1c reduction GLP-1s Lead to Greater Weight Loss and A1C Improvement Than Metformin in Patients with PCOS Most Patients with Type 2
Description
A 2022 study published in Diabetes, Obesity and Metabolism found that adults over 50 achieved clinically significant weight loss on semaglutide, with cardiovascular and metabolic risk reductions comparable to younger cohorts, though the authors noted the importance of individualized monitoring protocols for older patients given the higher baseline prevalence of comorbidities
Such a provider can help you make the right choice for your specific situation and needs
You can maximize the results of the medication by optimizing your nutrition, activity, stress and sleep
Cognitive decline Research has begun to elucidate the adverse impact of T2DM on cognitive function in PD
